Diffusion of Pharmaceutical Innovations in Health Systems

Rifat A. Atun, Ipek Gurol-Urganci and Desmond Sheridan
Additional contact information
Rifat A. Atun: Imperial College Business School, UK
Ipek Gurol-Urganci: Imperial College Business School, UK
Desmond Sheridan: Imperial College Business School, UK

Chapter 8 in Gaining Momentum:Managing the Diffusion of Innovations, 2010, pp 253-281 from World Scientific Publishing Co. Pte. Ltd.

Abstract: AbstractThe following sections are included:IntroductionInnovation ModelsHealth System Goals and ObjectivesHow Regulation Influences the Diffusion of Innovations in Health SystemsPrice regulationDirect price controlsProfit controlsReference pricingCross-Country Price Differentials and Parallel TradeGeneric entry and price competitionHealth technology assessmentChanges in Health System FinancingEffect of health insuranceCost sharingDrug budgets and prescribing limitsOrganizational ChangesGeneral practice fundholding in the UKManaged care in the USService ProvisionDisease managementFormulariesDiscussions and ConclusionsReferences

Keywords: Innovation; Diffusion; Product Development; Product Marketing (search for similar items in EconPapers)
Date: 2010
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.worldscientific.com/doi/pdf/10.1142/9781848163553_0008 (application/pdf)
https://www.worldscientific.com/doi/abs/10.1142/9781848163553_0008 (text/html)
Ebook Access is available upon purchase.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:wsi:wschap:9781848163553_0008

Ordering information: This item can be ordered from

Access Statistics for this chapter

More chapters in World Scientific Book Chapters from World Scientific Publishing Co. Pte. Ltd.
Bibliographic data for series maintained by Tai Tone Lim ().